Intellectual Property

The technology, covered by a number of world-wide patents at various prosecution stages, has been exclusively licensed from Rutgers University to Mito BioPharma, LLC. Mito BioPharma has exclusive world-wide rights to develop, market, and sell the patent technology. A key patent has been recently issued in the US (March 2019).  

Mito Biopharma has contracted Pepper Hamilton LLP as its sole patent agent.